Related Experiment Video
Updated: Jan 23, 2026

09:19
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
Published on: July 14, 2022
4.2K
Epigenome Remodeling in Cholangiocarcinoma
Colm J O'Rourke1, Juan Lafuente-Barquero1, Jesper B Andersen1
1Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.
Trends in Cancer
|June 19, 2019
Summary
Cholangiocarcinoma (CCA) research can advance by focusing on epigenetics. Understanding epigenome dysregulation offers new avenues for biomarkers and treatments for this challenging cancer.
Area of Science:
- Oncology
- Epigenetics
- Cancer Biology
Background:
- Cholangiocarcinoma (CCA) is a group of biliary tract cancers with poor prognosis and treatment resistance.
- Recurrent mutations in epigenetic regulators suggest epigenetic destabilization is key in CCA development.
- Biliary tumor epigenomes remain understudied, limiting our understanding of CCA.
Purpose of the Study:
- To advocate for an epigenome-oriented approach in cholangiocarcinoma research.
- To explore the links between epigenetics, molecular heterogeneity, cell origins, and tumor microenvironments in CCA.
- To discuss factors contributing to epigenome dysregulation and assess the translational potential of epigenomics in CCA.
Main Methods:
- This is an Opinion article, presenting a perspective on the role of epigenetics in CCA.
- It synthesizes current knowledge on CCA, epigenetic regulators, and potential causes of epigenome dysregulation.
- It assesses the potential of epigenomic approaches for biomarker and therapeutic development.
Main Results:
- An epigenome-focused strategy can connect diverse aspects of CCA research, including heterogeneity and the tumor microenvironment.
- Epigenome dysregulation in biliary tumors may stem from genetic, epigenetic, metabolic, microenvironmental, and physiological factors.
- Epigenomic insights hold promise for identifying novel biomarkers and therapeutic targets for CCA.
Conclusions:
- An epigenome-oriented approach is crucial for advancing cholangiocarcinoma research and understanding its complexities.
- Investigating the causes and consequences of epigenome dysregulation can reveal new therapeutic strategies.
- Epigenomics offers significant translational potential for developing effective treatments and biomarkers for CCA patients.
Related Concept Videos
Nucleosome Remodeling
10.8K
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
10.8K
Bone Remodeling
40.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.3K
Osteoclasts in Bone Remodeling
4.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.0K
Transcription Elongation Factors
13.5K
Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.5K
Eukaryotic Transcription Inhibitors
10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Self-Schemas
35.4K
In general, a schema is a mental construct consisting of a cluster or collection of related concepts (Bartlett, 1932). There are many different types of schemata, and they all have one thing in common: schemata are a method of organizing information that allows the brain to work more efficiently. When a schema is activated, the brain makes immediate assumptions about the person or object being observed.
35.4K

